U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT06807788) titled 'Evaluation of Platelet Aggregability in Patients with Takayasu's Arteritis' on Jan. 29.
Brief Summary: Inflammatory syndromes in general, and primary vasculitis specifically, present a high risk of cardiovascular involvement. Takayasu arteritis (TAK), for example, presents cardiovascular complications in up to 60% of cases. It is a systemic inflammatory disease that primarily affects large vessels, such as the aorta and its main branches. From a pathophysiological point of view, there are several causes that can lead to an exacerbated increase in cardiovascular risk in this population, including accelerated atherosclerosis, pro-infla...